MORGAN STANLEY - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 57 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q3 2023$8,634
-27.5%
6,693
-25.8%
0.00%
Q2 2023$11,905
+86.7%
9,0190.0%0.00%
Q1 2023$6,376
-69.0%
9,019
-67.1%
0.00%
Q4 2022$20,587
-84.0%
27,449
-81.6%
0.00%
Q3 2022$129,000
+9.3%
149,091
+41.8%
0.00%
Q2 2022$118,000
-39.5%
105,137
-39.5%
0.00%
Q1 2022$195,000
-41.6%
173,824
-16.7%
0.00%
Q4 2021$334,000
+554.9%
208,668
+887.0%
0.00%
Q3 2021$51,000
-71.2%
21,142
-62.0%
0.00%
Q2 2021$177,000
+18.8%
55,591
+26.1%
0.00%
Q1 2021$149,000
+893.3%
44,071
+974.9%
0.00%
Q4 2020$15,000
+7.1%
4,100
-24.1%
0.00%
Q3 2020$14,000
+100.0%
5,400
+131.5%
0.00%
Q2 2020$7,000
+600.0%
2,333
+366.6%
0.00%
Q1 2020$1,000
-87.5%
500
-77.4%
0.00%
Q4 2019$8,000
-89.9%
2,216
-91.6%
0.00%
Q3 2019$79,000
+132.4%
26,412
+98.0%
0.00%
Q2 2019$34,00013,3420.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Rubric Capital Management LP 16,756,120$18,767,0000.99%
Clearline Capital LP 3,058,596$3,426,0000.44%
SUVRETTA CAPITAL MANAGEMENT, LLC 9,142,067$10,239,0000.39%
DAFNA Capital Management LLC 1,096,513$1,228,0000.34%
Octagon Capital Advisors LP 1,000,000$1,120,0000.30%
Rock Springs Capital Management LP 6,230,275$6,978,0000.20%
Boxer Capital, LLC 2,250,000$2,520,0000.16%
Orbimed Advisors 7,109,954$7,963,0000.14%
Artal Group S.A. 1,500,000$1,680,0000.09%
SECTORAL ASSET MANAGEMENT INC 385,000$431,0000.09%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders